Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.43 |
| ▸ | MMP2 | P08253 | 2/20 | 0.43 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FDPS | P14324 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1831241 | 1.00 | SPHK1 (0.43) | SPHK1PSMD14PLA2G1BMMP2ATG4B | |
| Hydrochloric Acid SCHEMBL5448552 | 1.00 | SPHK1 (0.43) | SPHK1PSMD14PLA2G1BMMP2ATG4B | |
| Hydrochloric Acid SCHEMBL2783886 | 1.00 | SPHK1 (0.43) | SPHK1PSMD14PLA2G1BMMP2ATG4B | |
| Hydrochloric Acid SCHEMBL9864879 | 1.00 | SPHK1 (0.43) | SPHK1PSMD14PLA2G1BMMP2ATG4B | |
| Bromide SCHEMBL1840434 | 0.98 | SPHK1 (0.42) | SPHK1PSMD14PLA2G1BMMP2ATG4B | |
| SCHEMBL1838532 | 0.98 | SPHK1 (0.45) | SPHK1PSMD14PLA2G1BMMP2ATG4B | |
| SCHEMBL239716 | 0.98 | SPHK1 (0.45) | SPHK1PSMD14PLA2G1BMMP2ATG4B | |
| SCHEMBL239692 | 0.98 | SPHK1 (0.45) | SPHK1PSMD14PLA2G1BMMP2ATG4B | |
| SCHEMBL238534 | 0.98 | SPHK1 (0.45) | SPHK1PSMD14PLA2G1BMMP2ATG4B | |
| SCHEMBL15646327 | 0.98 | SPHK1 (0.45) | SPHK1PSMD14PLA2G1BMMP2ATG4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2848336-B1 | METHOD FOR MANUFACTURING HOLLOW METAL NANOPARTICLES | LG CHEMICAL LTD (KR) | 2017-04-26 | — | — | EP | claimed |
| EP-1809279-B1 | PARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR | BAXTER INT (US) | 2013-05-29 | — | — | EP | claimed |
| EP-1686962-B9 | NANOPARTICULATE COMPOSITIONS HAVING A PEPTIDE AS A SURFACE STABILIZER | ELAN PHARMA INT LTD (IE) | 2012-10-03 | — | — | EP | claimed |
| EP-1871345-B1 | NANOPARTICULATE ERLOTINIB FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2012-08-01 | — | — | EP | claimed |
| EP-1585502-B9 | FAST-DISINTEGRATING SOLID DOSAGE FORMS BEING NOT FRIABLE AND COMPRISING PULLULAN | ELAN PHARMA INT LTD (IE) | 2012-05-09 | — | — | EP | claimed |
| EP-1553927-B9 | GEL-STABILIZED NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | ELAN PHARMA INT LTD (IE) | 2011-09-21 | — | — | EP | claimed |
| EP-1585502-B1 | FAST-DISINTEGRATING SOLID DOSAGE FORMS BEING NOT FRIABLE AND COMPRISING PULLULAN | ELAN PHARMA INT LTD (IE) | 2011-06-29 | — | — | EP | claimed |
| EP-1686962-B1 | NANOPARTICULATE COMPOSITIONS HAVING A PEPTIDE AS A SURFACE STABILIZER | ELAN PHARMA INT LTD (IE) | 2011-05-18 | — | — | EP | claimed |
| EP-1553927-B1 | GEL-STABILIZED NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | ELAN PHARMA INT LTD (IE) | 2010-11-10 | — | — | EP | claimed |
| EP-1490030-B2 | NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS | ELAN PHARMA INT LTD (IE) | 2010-07-14 | — | — | EP | claimed |
| EP-1895984-B1 | NANOPARTICULATE IMATINIB MESYLATE FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2010-03-03 | — | — | EP | claimed |
| EP-1898882-B1 | NANOPARTICULATE EBASTINE FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2009-10-28 | — | — | EP | claimed |
| EP-1617816-B1 | NANOPARTICULATE MELOXICAN FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2009-05-13 | — | — | EP | claimed |
| EP-1651189-B1 | NOVEL METAXALONE COMPOSITIONS | ELAN PHARMA INT LTD (IE) | 2008-12-03 | — | — | EP | claimed |
| EP-1658053-B1 | NOVEL COMPOSITIONS OF SILDENAFIL FREE BASE | ELAN PHARMA INT LTD (IE) | 2008-02-27 | — | — | EP | claimed |
| EP-1490025-B1 | NANOPARTICULATE COMPOSITIONS OF MAP KINASE INHIBITORS | ELAN PHARMA INT LTD (IE) | 2008-02-13 | — | — | EP | claimed |
| EP-1443912-B1 | COMPOSITIONS HAVING A COMBINATION OF IMMEDIATE RELEASE AND CONTROLLED RELEASE CHARACTERISTICS | ELAN PHARMA INT LTD (IE) | 2007-08-29 | — | — | EP | claimed |
| EP-1429731-B1 | NANOPARTICULATE INSULIN FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2007-01-03 | — | — | EP | claimed |
| EP-1490030-B1 | NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS | ELAN PHARMA INT LTD (IE) | 2006-10-25 | — | — | EP | claimed |
| EP-1115828-B1 | LAUNDRY DETERGENT AND/OR FABRIC CARE COMPOSITIONS COMPRISING A CHEMICAL ENTITY WHICH CONTAINS A DEPOSITION AID WITH A HIGH AFFINITY FOR CELLULOSE, A SURFACTANT AND A PROTEASE | PROCTER & GAMBLE (US) | 2006-04-12 | — | — | EP | claimed |